Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Budget slips happen, but you can regain stability with a simple plan. Identify leaks, prioritize essentials, and set a realistic spending cap to regain confidence.
24,983 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Stellantis faces a pivotal push to revive overseas markets and lift investor confidence. This deep-dive explores the ...
A key Michigan district flipped Democrat in a special election, signaling rising concern over inflation and auto tari...
A CDC director nominee faced tough questions about political interference and whether she would defy pressure from th...
Stripe's Patrick Collison warns a surge in token theft is upending the AI startup landscape, forcing changes to free ...
Bank earnings just dropped fresh clues about how Americans are spending, borrowing, and saving. This deep dive breaks...
Japan's quarterly sale of US Treasuries jolts bond markets, amplifying yield moves that could shape Bitcoin and other...
A clever scam pattern lets a second fake amazon call seem legitimate, nudging victims to reveal banking details. This...
Beyond Meat faces headwinds, but a protein drinks turnaround catalyst could change the game. This article breaks down...
Bitcoin ETFs pulled about $2 billion in net inflows in April, the strongest monthly total so far this year. May opene...
Investors are weighing a bold ripple (xrp) price prediction as regulatory chatter and on-chain expansion add fuel to ...
BlackRock’s bitcoin move was driven by client redemptions tied to ETF outflows, not a shift in the long-term crypto t...